ViewpointIs Hospital Admission for Heart Failure Really Necessary?: The Role of the Emergency Department and Observation Unit in Preventing Hospitalization and Rehospitalization
Key Words
Abbreviations and Acronyms
Cited by (0)
This work was supported in part by grant K23HL085387 from the National Heart, Lung, and Blood Institute. Dr. Collins is a consultant for Trevena, Radiometer, The Medicines Company, and Novartis; and has received research support from the National Institutes of Health, Medtronic, Novartis, and Abbott Point of Care. Dr. Pang is a consultant for Novartis, Otsuka, Trevena, and Palatin Technologies; has received research support from Abbott and Alere; and has received honoraria from Alere, Beckman Coulter, Momentum Research, Nile Therapeutics, and MyLife. Dr. Fonarow has received research support from Medtronic, Novartis, and Gambro. Dr. Gheorgiade has received support from Abbott Laboratories, Astellas, AstraZeneca, Bayer Schering Pharma AG, Cardiorentis Ltd., CorThera, Cytokinetics, CytoPherx, Inc., DebioPharm S.A., Errekappa Terapeutici, GlaxoSmithKline, Ikaria, Intersection Medical, Inc, Johnson & Johnson, Medtronic, Merck & Co., Inc., Novartis Pharma AG, Ono Pharmaceuticals USA, Otsuka Pharmaceuticals, Palatin Technologies, Pericor Therapeutics, Protein Design Laboratories, sanofi-aventis, Sigma Tau, Solvay Pharmaceuticals, Sticares InterACT, Takeda Pharmaceuticals North America, Inc., and Trevena Therapeutics; and has received significant (>$10,000) support from Bayer Schering Pharma AG, DebioPharm S.A., Medtronic, Novartis Pharma AG, Otsuka Pharmaceuticals, Sigma Tau, Solvay Pharmaceuticals, Sticares InterACT, and Takeda Pharmaceuticals North America, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.